Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Kelly A Romano Net Worth & Insider Trades

Kelly A Romano - Director, Athira Pharma, Inc

As of May 22, 2023

What is Kelly A Romano's Net Worth?

The current estimated net worth of Athira Pharma, Inc's Director, Kelly A Romano, is estimated to be about $434.73K . Kelly A Romano owns about 38,315 units of Athira Pharma, Inc common stock. In the last 3 years at Athira Pharma, Inc, Kelly A Romano has sold an estimated value of $0 worth.

What is Kelly A Romano's Past Insider Trading?

Kelly A Romano's largest purchase order was 8,000 units , worth over $104.88K on April 1, 2022. In total, Kelly A Romano has made about 5 transactions over 3 years of their time at Athira Pharma, Inc. Kelly A Romano usually trades in December and May, with the busiest year in 2022. The most recent transaction was a purchase order of 30,000 units , worth over $98.7K on December 6, 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kelly A Romano

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Kelly A Romano's' Mailing Address?

  • Mailing address is C/o Dorman Products, Inc. 3400 East Walnut Street Colmar PA 18915 PA

What are Athira Pharma, Inc's Past Insider Trades?

Athira Pharma, Inc's most recent insider trade came on June 9, 2023 by Andrew Gengos who bought 15,000 units worth $51.45K . In the last 3 years, insiders at Athira Pharma, Inc have sold an estimated value of $53.79K and bought an estimated value of $60.97M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Hans Moebius, Chief Medical Officer,  Kevin Church, Chief Scientific Officer,  and Glenna Mileson, Chief Financial Officer .

Athira Pharma, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...